Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.405EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.405ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.405ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.405EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.405EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.405ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.296EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.296EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.296ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.296ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.296EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.296EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.296ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.296ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.412EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.1.412EWon-ECACACAATCGATGCGCAGTA20502636526346R-1441.38South Korea
B.1.1.412ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.1.412ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3577.4Germany
B.1.1.412EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-1579.08China
B.1.1.412EHuang-EGCAGCAGTACGCACACAATC20552637626357R-2624.46China
B.1.1.412ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.412ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.421EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.421ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.421ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.421EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used